ADMELOG
insulin lispro
- Strength
- 100 U/mL
- Form
- Injection, Solution
- Class
- Insulin Analog
Sanofi-Aventis U.S. LLC
Not stocked by us — reference only
Insulin lispro
Listed by Eli Lilly and Company
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous, Subcutaneous |
| Drug class | Insulin Analog |
| Approval route | BLA — biologic licence |
| NDC code | 0002-7516 |
| FDA application | BLA020563 |
| RxNorm concept | 242120 |
| Package sizes listed | 1 |
| Marketed since | February 1998 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
insulin lispro
Sanofi-Aventis U.S. LLC
Not stocked by us — reference only
insulin lispro
Sanofi-Aventis U.S. LLC
Not stocked by us — reference only
insulin lispro
REMEDYREPACK INC.
Not stocked by us — reference only
insulin lispro
Sanofi-Aventis U.S. LLC
Not stocked by us — reference only
Insulin lispro
A-S Medication Solutions
Not stocked by us — reference only
Insulin lispro
A-S Medication Solutions
Not stocked by us — reference only
Insulin lispro
Eli Lilly and Company
Not stocked by us — reference only
Insulin lispro
Eli Lilly and Company
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.